药明

药明生物（WuXi Biologics）是香港上市公司（代码：2269），我们是全球领先的开放式、一体化生物制药能力和技术平台，旗下包括无锡药明康德生物技术股份有限公司、上海药明生物技术有限公司、苏州药明康德检测检验有限责任公司，并在美国和英国设有子公司。公司为全球生物制药公司和生物技术公司提供全方位的端到端研发服务，帮助任何人、任何公司发现、开发及生产生物药，实现从概念到商业化生产的全过程，加速全球生物药研发进程，降低研发成本，造福病患。目前，公司规模达到2500多人，有200多位拥有海外高等学位和工作经验的海归科学家，拥有丰富的欧美市场抗体开发、生产、质量控制、临床前研究和注册的经验，打造了世界一流的生物药研究、开发及生产团队。
WuXi Biologics (Stock Code: 2269.HK, the "Company"), a Hong Kong-listed company, is a global leading biologics services provider that offers comprehensive, integrated and highly customizable services. It includes WuXi AppTec Biopharmaceuticals Co., Ltd., WuXi Biologics (Shanghai) Co., Ltd., WuXi AppTec (Suzhou) Testing Technology Co., Ltd., and subsidiaries in US and UK. The company offersmultinational pharmaceutical and biotechnologicalcompanies in the world end-to-end solutions empoweringanyone and any company to discover, develop and manufacture biologics from concept to commercial manufacturing. Our services are designed to help our worldwide clients shorten the discovery and development time and lower the cost of biologics.
At present, the company has over 2500 employees, including more than 200 overseas returnees and scientists with advanced degrees and work experience abroad. We have rich experience in antibody development, manufacturing, quality control, preclinical research and registration in European and American markets, enabling us create a world-class pharmaceutical biologics discovery, development and manufacturing team.
苏州药明康德检测检验有限责任公司成立于2012年5月，是药明康德全资子公司，规划建筑面积1万平方米，主要为国内外客户提供高质量的检测技术开发及技术咨询服务，包括生物制品样品检测、食品检测、药品检测、医疗器械检测、环境及农药检测等。